In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Staar lens wins CMS new technology IOL recognition

This article was originally published in The Gray Sheet

Executive Summary

Medicare will provide an additional reimbursement of $50 per lens when Staar Surgical's Afinity Collamer Aspheric foldable intraocular lens is provided to a cataract patient in an ambulatory surgical center, following the lens' designation as a new technology intraocular lens by CMS, announced March 17. To receive NTIOL recognition, an IOL must be FDA-approved with labeling and advertising consistent with the specific claim for which CMS approval is being sought, and the IOL must provide measurable, clinically meaningful improved patient outcomes over other available IOLs. The Staar Afinity IOL, which has been cleared for enhanced reimbursement through Feb. 26, 2011, reduces spheric aberrations to improve visual acuity, Staar says

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts